Slippery slope of triglycerides: they are associated with risk, but in the statin era, does targeting them confer benefit?
Karol E. Watson KE and Wiesner P Circ Cardiovasc Qual Outcomes. Originally pub. March 8, 2016 http://circoutcomes.ahajournals.org/content/early/2016/03/08/CIRCOUTCOMES.116.002675
Leggi